Products
Online Inquiry
Dehydroabietic acid
Cat. No.:
0225LY-0687
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by HPLC, and LC-MS.
Size:
Add to basket
Product Overview
Description:
Dehydroabietic acid is an EBV-EA activation inhibitor and a food-derived compound that treats obesity-related conditions by lowering plasma insulin, glucose, and triglyceride levels, as well as showing anti-pepsin effects.
Synonym:
Dehydroabietate; 1740-19-8; Abieta-8,11,13-trien-18-oic acid; Abietic acid, dehydro-; (-)-Dehydroabietic acid; (+)-Dehydroabietic acid; 1-Phenanthrenecarboxylic acid, 1,2,3,4,4a,9,10,10a-octahydro-1,4a-dimethyl-7-(1-methylethyl)-, (1R,4aS,10aR)-; 13-Isopropylpodocarpa-8,11,13-trien-15-oic acid; Podocarpa-8,11,13-trien-15-oic acid, 13-isopropyl-; Isopropyl podocarpa-8,11,13-trien-15-oic acid; (1R,4aS,10aR)-1,4a-dimethyl-7-propan-2-yl-2,3,4,9,10,10a-hexahydrophenanthrene-1-carboxylic acid; Rel-(1R,4aS,10aR)-7-Isopropyl-1,4a-dimethyl-1,2,3,4,4a,9,10,10a-octahydrophenanthrene-1-carboxylicacid
CAS No.:
1740-19-8
Compound CID:
94391
Formula:
C20H28O2
Formula Weight:
300.44
Specification
Relative Density:
1.058 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Dehydroabietic acid can be used in medicinal chemistry to explore its role as a scaffold for developing anti-inflammatory agents.
Library Information
Target:
EBV
Receptor:
EBV-EA
Pathways:
Microbiology/Virology
Plate Number:
AOCL-9
Plate Location:
h4
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10mM DMSO
DMSO Max Solubility:
125 mg/mL; 416.06 mM
Solubility:
Soluble in chloroform, dichloromethane, ethyl acetate, acetone, etc.
